Noxopharm Balance Sheet Health
Financial Health criteria checks 6/6
Noxopharm has a total shareholder equity of A$5.5M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$6.8M and A$1.3M respectively.
Key information
0%
Debt to equity ratio
AU$0
Debt
Interest coverage ratio | n/a |
Cash | AU$2.32m |
Equity | AU$5.50m |
Total liabilities | AU$1.29m |
Total assets | AU$6.78m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: NOX's short term assets (A$4.8M) exceed its short term liabilities (A$1.2M).
Long Term Liabilities: NOX's short term assets (A$4.8M) exceed its long term liabilities (A$42.2K).
Debt to Equity History and Analysis
Debt Level: NOX is debt free.
Reducing Debt: NOX currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NOX has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: NOX has sufficient cash runway for 1.9 years if free cash flow continues to grow at historical rates of 7.5% each year.